ProForma 2.0
Not calculated for this record
P1
Aliases: P1
Normalized sequence
KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF
34 amino acids
Release PepDiana-V1-20260620
35
Activity records
1
Source papers
35
Positive
0
Negative / threshold
Cross-layer links
Versioned scientific descriptors
No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.
Molecular weight
Not calculated
Molecular formula
Not calculated
Theoretical pI
Not calculated
Net charge at pH 7
Not calculated
GRAVY
Not calculated
Instability index
Not calculated
Aromaticity
Not calculated
Topological polar surface area
Not calculated
cLogP
Not calculated
Hydrogen-bond donors
Not calculated
Hydrogen-bond acceptors
Not calculated
Rotatable bonds
Not calculated
Method: Not recorded
Tool: Not recorded
Calculated: Not recorded
ProForma 2.0
Not calculated for this record
HELM 2.0
Not calculated for this record
Canonical SMILES
Not calculated for this record
Isomeric SMILES
Not calculated for this record
Paper-level observations
Table 1: Hydrostatin-AMP2 MIC against Escherichia coli is 16 μg/mL.
Table 1: Hydrostatin-AMP2 MBC against Escherichia coli is 32 μg/mL (reported as MIC/MBC 16/32).
Table 1: Hydrostatin-AMP2 MIC against Klebsiella pneumoniae 44 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 48 is 16 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 49 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 50 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against K. pneumoniae 51 is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against Propionibacterium acnes is 32 μg/mL.
Table 1: Hydrostatin-AMP2 MIC against Staphylococcus aureus is 32 μg/mL.
Table 2: Control MIC of Hydrostatin-AMP2 against E. coli is 16 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 50 mM NaCl is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 100 mM NaCl is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 150 mM NaCl is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 200 mM NaCl is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 1 mM CaCl2 is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 2 mM CaCl2 is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli in 4 mM CaCl2 is 128 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 1h in human serum is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 2h in human serum is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 3h in human serum is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 4h in human serum is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 4°C treatment is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 37°C treatment is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 80°C treatment is 32 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli after 100°C treatment is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli at pH 2 is 64 μg/mL.
Table 2: MIC of Hydrostatin-AMP2 against E. coli at pH 12 is 64 μg/mL.
Section 2.6: The inhibition of Hydrostatin-AMP2 on the biofilm formation of S. aureus reached 71.02% at the concentration of 2 × MIC.
Section 2.6: When the peptide concentration changed from 4 × MIC to 8 × MIC, the scavenging effect of Hydrostatin-AMP2 on mature biofilms increased from 50.02% to 60.99%.
Section 2.6: When the peptide concentration changed from 4 × MIC to 8 × MIC, the scavenging effect of Hydrostatin-AMP2 on mature biofilms increased from 50.02% to 60.99%.
Table 3: Cell death of L929 cells treated with Hydrostatin-AMP2 is 8.08%.
Table 3: Cell death of HaCaT cells treated with Hydrostatin-AMP2 is 5.89%.
Table 3: Cell death of RAW264.7 cells treated with Hydrostatin-AMP2 is 10.81%.
Table 3: Hemolysis of human erythrocytes by Hydrostatin-AMP2 is 4.6%.
Section 2.10: 20 μg/mL of Hydrostatin-AMP2 could reduce iNOS expression by 87.5%.
Citation and release provenance
Cite this identity as PepDiana record PEPDIA-PLP-003777, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.
Record updated: 2026-06-22T07:14:26.229247+00:00